[Acute hyperphosphatemia secondary to phosphate administration for bowel preparation].
We report a 75-years-old woman, stable on a three-weekly hemodialysis program over a period of 3 years, who develop acute hyperphosphatemia secondary to phosphate administration for bowel preparation. The quick clinical diagnosis and the treatment with intensive hemodialysis resulted in a correction of hyperphosphatemia, hypocalcemia, acidemia and other electrolyte abnormalities. The phosphate cathartics are contraindicated in patients with severe renal insufficient or in dialysis program. Our case shows the severe side effects secondary to injudicious use of sodium phosphate cathartics.
Gutiérrez
E
E
Servicio de Nefrología, Hospital 12 de Octubre, Madrid. eduardogm90@hotmail.com
González
E
E
Hernández
E
E
Herrero
J C
JC
Manzanera
M J
MJ
García
J A
JA
Domínguez-Gil
B
B
Praga
M
M
D000208:Acute Disease; D000368:Aged; D002400:Cathartics / Q000008:administration & dosage / Q000009:adverse effects*; D004733:Enema / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications / Q000628:therapy; D010710:Phosphates / Q000008:administration & dosage / Q000009:adverse effects*; D010758:Phosphorus / Q000097:blood; D010760:Phosphorus Metabolism Disorders / Q000097:blood / Q000139:chemically induced* / Q000628:therapy; D006435:Renal Dialysis; D016896:Treatment Outcome; D014883:Water-Electrolyte Imbalance / Q000097:blood / Q000139:chemically induced* / Q000628:therapy
D002400:Cathartics; D010710:Phosphates; D010758:Phosphorus; C018279:sodium phosphate